200 related articles for article (PubMed ID: 30147370)
1. Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil.
Kurata T; Fushida S; Kinoshita J; Oyama K; Yamaguchi T; Okazaki M; Miyashita T; Tajima H; Ninomiya I; Ohta T
Cancer Manag Res; 2018; 10():2729-2742. PubMed ID: 30147370
[TBL] [Abstract][Full Text] [Related]
2. Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.
Tsukada T; Fushida S; Harada S; Terai S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2013 Apr; 42(4):1167-74. PubMed ID: 23443842
[TBL] [Abstract][Full Text] [Related]
3. Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.
Saito H; Fushida S; Harada S; Miyashita T; Oyama K; Yamaguchi T; Tsukada T; Kinoshita J; Tajima H; Ninomiya I; Ohta T
Gastric Cancer; 2018 Jan; 21(1):55-67. PubMed ID: 28540637
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway.
Shinbo T; Fushida S; Tsukada T; Harada S; Kinoshita J; Oyama K; Okamoto K; Ninomiya I; Takamura H; Kitagawa H; Fujimura T; Yashiro M; Hirakawa K; Ohta T
Oncol Rep; 2015 Feb; 33(2):553-8. PubMed ID: 25435013
[TBL] [Abstract][Full Text] [Related]
5. The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.
Tsukada T; Fushida S; Harada S; Yagi Y; Kinoshita J; Oyama K; Tajima H; Fujita H; Ninomiya I; Fujimura T; Ohta T
Int J Oncol; 2012 Aug; 41(2):476-82. PubMed ID: 22614335
[TBL] [Abstract][Full Text] [Related]
6. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
7. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence.
Kawka E; Witowski J; Sandoval P; Rudolf A; Vidal AR; Cabrera ML; Jörres A
Perit Dial Int; 2019; 39(1):35-41. PubMed ID: 30478141
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway.
Heo JY; Do JY; Lho Y; Kim AY; Kim SW; Kang SH
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356903
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 signaling blockade attenuates gastric cancer cell-induced peritoneal mesothelial cell fibrosis and alleviates peritoneal dissemination both in vitro and in vivo.
Miao ZF; Zhao TT; Wang ZN; Miao F; Xu YY; Mao XY; Gao J; Wu JH; Liu XY; You Y; Xu H; Xu HM
Tumour Biol; 2014 Apr; 35(4):3575-83. PubMed ID: 24347485
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.
Yang Y; Liu K; Liang Y; Chen Y; Chen Y; Gong Y
Int J Clin Exp Pathol; 2015; 8(3):2746-54. PubMed ID: 26045780
[TBL] [Abstract][Full Text] [Related]
12. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.
Yin S; Miao Z; Tan Y; Wang P; Xu X; Zhang C; Hou W; Huang J; Xu H
Cancer Med; 2019 Apr; 8(4):1731-1743. PubMed ID: 30791228
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines.
Terashima M; Sakai K; Togashi Y; Hayashi H; De Velasco MA; Tsurutani J; Nishio K
Springerplus; 2014; 3():417. PubMed ID: 25140293
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A derived from mast cells contributes to fibrosis in gastric cancer with peritoneal dissemination.
Gunjigake K; Kinoshita J; Yamaguchi T; Saito H; Fujimori D; Horiike T; Harada S; Tajima H; Ninomiya I; Ohta T; Fushida S
Gastric Cancer; 2021 Jan; 24(1):31-44. PubMed ID: 32488650
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor is a positive regulator of epithelial-mesenchymal transition and promotes the adhesion with gastric cancer cells in human peritoneal mesothelial cells.
Jiang CG; Lv L; Liu FR; Wang ZN; Na D; Li F; Li JB; Sun Z; Xu HM
Cytokine; 2013 Jan; 61(1):173-80. PubMed ID: 23073116
[TBL] [Abstract][Full Text] [Related]
17. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
[TBL] [Abstract][Full Text] [Related]
18. Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis.
Xie S; Xu F; Lu Y; Zhang Y; Li X; Yu M; Cui W
Front Pharmacol; 2022; 13():890881. PubMed ID: 35800446
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells.
Shi Y; Tao M; Ni J; Tang L; Liu F; Chen H; Ma X; Hu Y; Zhou X; Qiu A; Zhuang S; Liu N
Front Pharmacol; 2021; 12():722638. PubMed ID: 34526901
[No Abstract] [Full Text] [Related]
20. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
